Mestinon

Mestinon

pyridostigmine bromide

Manufacturer:

Transfarma Medica Indah

Marketer:

A Menarini
Concise Prescribing Info
Contents
Pyridostigmine Br
Indications/Uses
Myasthenia gravis. Paralytic ileus & post-op urinary retention.
Dosage/Direction for Use
Myasthenia gravis Adult 30-120 mg daily. Childn 6-12 yr 60 mg daily, <6 yr 30 mg daily. Doses should be increased gradually in increments of 15-30 mg daily. Paralytic ileus & post-op urinary retention Adult 60-240 mg daily. Childn 15-60 mg daily.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to bromides. GI or urinary obstruction. Bronchial asthma.
Special Precautions
Bradycardia, recent coronary occlusion, hypotension, vagotonia, peptic ulcer, epilepsy, parkinsonism. Lower doses in renal disease. Pregnancy & lactation.
Adverse Reactions
Nausea, vomiting, increased salivation, diarrhea, abdominal cramps.
Drug Interactions
Potentiates actions of morphine derivatives & barbiturates.
MIMS Class
Neuromuscular Disorder Drugs
ATC Classification
N07AA02 - pyridostigmine ; Belongs to the class of anticholinesterase. Used as parasympathomimetics.
Presentation/Packing
Form
Mestinon sugar-coated tab 60 mg
Packing/Price
150's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in